Not finding it? Sign in to also search OpenAlex live.
-
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents
Andrew John Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil H. Goldstein, +84 more
173citations -
Restoration of Cone Sensitivity to Individuals with Congenital Photoreceptor Blindness within the Phase 1/2 Sepofarsen Trial2022 Ophthalmology Science article Biochemistry, Genetics and Molecular Biology Retinal Development and Disorders Open access
Artur V. Cideciyan, Samuel G. Jacobson, Allen C. Ho, Arun K. Krishnan, Alejandro J. Román, Alexandra V. Garafalo, +8 more
18citations -
A scientific benchmark for elasto-plastic constitutive modeling - Part II: blind predictions, calibration strategies, and benchmark results2026 International Journal of Material Forming article Engineering Metal Forming Simulation Techniques Open access
Lorenz MAIER, Erik Walz, M. Hofmann, Joana Rebelo-Kornmeier, Rongfei Juan, Junhe Lian, +7 more
3citations -
A scientific benchmark for elasto-plastic constitutive modeling - Part II: blind predictions, calibration strategies, and benchmark results2026 International Journal of Material Forming article Engineering Metal Forming Simulation Techniques Open access
Lorenz MAIER, Erik Walz, M. Hofmann, Joana Rebelo-Kornmeier, Rongfei Juan, Junhe Lian, +7 more
0citations -
The importance of hair in human perception of electric fields – A double-blind repeated measures study2026 Scientific Reports article Biochemistry, Genetics and Molecular Biology Electromagnetic Fields and Biological Effects Open access
Kathrin Jankowiak, Andrea Kaifie, Julia Krabbe, Maike Franziska Dohrn, Simon Kimpeler, Frederik Mingers, +2 more
0citations -
Endolymphatic duct blockage for Ménière’s disease: a double-blind, randomised controlled trial2026 The Lancet Regional Health - Europe article Neuroscience Vestibular and auditory disorders Open access
Annejet Alida Schenck, Raymond van de Berg, Thomas T. A. Peters, Yvette E. Smulders, Stephanie M. Winters, Stefan Böhringer, +8 more
0citations -
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial
Manouk den Toom, Laura M. E. Blanken, Inge Horn, Selene R. T. Veerman, Joris J. B. van der Vlugt-Molenaar, Mariken Beatrijs de Koning, +14 more
0citations -
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial2020 The Lancet Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access cited by 48 patents
Jean‐Yves Blay, César Serrano, Michael Charles Heinrich, John Raymond Zalcberg, Sebastian Bauer, Hans A. J. Gelderblom, +11 more
430citations -
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 1 patent
Désirée M F M van der Heijde, Lianne S. Gensler, Atul A. Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, +6 more
134citations -
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes2020 Diabetologia article Biochemistry, Genetics and Molecular Biology Diabetes and associated disorders Open access cited by 2 patents
Bart Keymeulen, André van Maurik, João Joaquim de Oliveira, Rene J. McLaughlin, Rachel Gittelman, Bart O. Roep, +7 more
51citations -
TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
Ellis Niemantsverdriet, Yousra J. Dakkak, Leonie E. Burgers, Femke Bonte‐Mineur, Gerda M. Steup‐Beekman, Sjoerd M. van der Kooij, +4 more
35citations -
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
Jaume Capdevila, Arkadiy L. Klochikhin, Sophie Leboulleux, Pavel A. Isaev, Corin Badiu, Bruce Robinson, +12 more
20citations -
Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments (ORANGE Segments): a multicentre, single-blind, randomised controlled trial2025 The Lancet Regional Health - Europe article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jasper P. Sijberden, Christoph Kuemmerli, Francesca Ratti, Mathieu D’Hondt, Robert Peter Sutcliffe, Roberto Ivan TROISI, +22 more
14citations -
Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies2026 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, Walter P. Maksymowych, Victoria Navarro‐Compán, Désirée M F M van der Heijde, Robert Landewé, Pedro Machado, +10 more
1citations